Hepatocellular carcinoma surveillance—Utilization, barriers and the impact of changing aetiology
Hepatocellular carcinoma (HCC) is the third leading cause of cancer death worldwide.
Surveillance for HCC is critical for early detection and treatment, but fewer than one-quarter …
Surveillance for HCC is critical for early detection and treatment, but fewer than one-quarter …
National prevalence estimates for steatotic liver disease and subclassifications using consensus nomenclature
BP Lee, JL Dodge, NA Terrault - Hepatology, 2024 - journals.lww.com
National prevalence estimates for steatotic liver disease an... : Hepatology National
prevalence estimates for steatotic liver disease and subclassifications using consensus …
prevalence estimates for steatotic liver disease and subclassifications using consensus …
[HTML][HTML] the heart of NAFLD
NWS Chew, S Kannan, B Chong, Y Chin… - Frontiers in …, 2023 - frontiersin.org
The silent obesity epidemic has led to the rising global prevalence of non-alcoholic fatty liver
disease (NAFLD). This metabolic burden is a growing public health concern as forecast …
disease (NAFLD). This metabolic burden is a growing public health concern as forecast …
Type 2 diabetes mellitus and cardiometabolic outcomes in metabolic dysfunction-associated steatotic liver disease population
NWS Chew, XH Pan, B Chong, C Chandramouli… - Diabetes Research and …, 2024 - Elsevier
The metabolic syndrome, characterized by type 2 diabetes mellitus (T2DM), hypertension,
hyperlipidemia, and obesity, collectively increases the risk of cardiovascular diseases …
hyperlipidemia, and obesity, collectively increases the risk of cardiovascular diseases …
Changing the nomenclature from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease is more than a change in terminology
EL Yoon, DW Jun - Clinical and Molecular Hepatology, 2023 - e-cmh.org
In this issue of Clinical and Molecular Hepatology, Gofton et al. 1 reviewed the difference
between metabolic dysfunctionassociated fatty liver disease (MAFLD) and non-alcoholic …
between metabolic dysfunctionassociated fatty liver disease (MAFLD) and non-alcoholic …
Cross‐sectional study on stigma and motivation to adhere to lifestyle modification among vulnerable populations with fatty liver disease
SP Medina, RG Kim, C Magee… - Obesity Science & …, 2023 - Wiley Online Library
Objectives Adherence to lifestyle modification (diet, exercise, and alcohol cessation) for fatty
liver disease (FLD) management remains challenging. The study examined stigma, barriers …
liver disease (FLD) management remains challenging. The study examined stigma, barriers …
[PDF][PDF] PAKISTAN SOCIETY OF HEPATOLOGY (PSH) POSITION STATEMENT: RENAMING NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) TO STEATOTIC …
The Nomenclature of diseases intends to have a system whereby diagnosis can be suitably
catalogued without ambiguity or confusion. Therefore, the nomenclature of nonalcoholic fatty …
catalogued without ambiguity or confusion. Therefore, the nomenclature of nonalcoholic fatty …